<ѻý>To Combat Opioid Epidemic, Step Up Safe Prescribing Practices, Expert Urgesѻý> Overprescribing a continuing problem, Benjamin Davies tells urologists Dec 02, 2022
<ѻý>Pre-Op Axitinib Helps for Partial Nephrectomy of Complex Renal Tumorsѻý> Approach in small ongoing trial resulted in reduction in tumor size and complexity Dec 02, 2022
<ѻý>Sequential Gemcitabine/Docetaxel Promising in NMIBC After BCG Relapseѻý> But patients with BCG-refractory disease may be better suited for cystectomy Dec 02, 2022
<ѻý>New IDH1 Inhibitor Wins FDA Approval for Acute Myeloid Leukemiaѻý> Olutasidenib led to a 35% response rate in a study of adults with previously treated AML Dec 02, 2022
<ѻý>Still Using Medical Jargon? Prepare to Be Misunderstoodѻý> Survey shows just how often individuals misinterpret common medical phrases Dec 01, 2022
<ѻý>Metastasis-Directed Therapy May Delay ADT in Advanced Prostate Cancerѻý> Surgery or radiation delayed initiation of systemic therapy by 18 months Nov 29, 2022
<ѻý>Life and Death in 12 Hoursѻý> ICU nurse Christin Thankachan on providing comfort during life's darkest moments Nov 29, 2022 podcast
<ѻý>Lung Cancer Survival High for Patients With Early, Screen-Detected Tumorsѻý> Two decades of I-ELCAP follow-up data show 80% lung cancer-specific survival rate Nov 28, 2022
<ѻý>Robotic Surgery Proves Its Mettle for Liver Cancerѻý> Fewer cases of liver failure, similar survival versus open liver resection in matched analysis Nov 23, 2022
<ѻý>Persistent Lymphadenopathy and Neck Abscesses in a Healthy Boyѻý> Histopathological test results were central to ultimate diagnosis Nov 23, 2022
<ѻý>FDA OKs First Gene Therapy for Hemophilia Bѻý> Hemgenix reduced rate of annual bleeds, eliminated need for factor IX prophylaxis therapy Nov 22, 2022
<ѻý>Exercise During Chemo Shows Benefits for Cardiorespiratory Fitnessѻý> However, patients who exercise after chemo also ultimately see benefits too Nov 21, 2022
<ѻý>RT After Breast-Conserving Surgery Shows No Survival Advantage Decades Laterѻý> But "that's not the intent of radiation therapy," says outside expert Nov 18, 2022
<ѻý>Year in Review: Hemophiliaѻý> Gene therapy continues to show promise in clinical trials, but is it ready for the clinic? Nov 17, 2022
<ѻý>Primary Care Visits Prior to Cancer Diagnosis Tied to Lower Mortalityѻý> Most benefit with annual visits, but even some use linked to better outcomes Nov 16, 2022
<ѻý>Melanoma Resistant to Anti-PD-1 Responds to Tumor Infiltrating Lymphocytesѻý> Almost a third of patients had objective responses, which deepened over time, study showed Nov 16, 2022
<ѻý>AMA Votes to Oppose Punishing Doctors When Necessary Care Results in Fetal Deathѻý> Doctors recount horrors of physician and patient arrests after loss of pregnancy Nov 15, 2022
<ѻý>Allogeneic CAR T-Cell Therapy Shows Early Promise in Kidney Cancerѻý> CTX130 yields sustained complete response in one patient with relapsed/refractory disease Nov 15, 2022
<ѻý>FDA OKs First Antibody-Drug Conjugate for Platinum-Resistant Ovarian Cancerѻý> Mirvetuximab soravtansine produced responses in almost a third of patients in pivotal trial Nov 15, 2022
<ѻý>Mixed Results With Fecal Transplant to Stimulate Cancer Immunotherapy Responseѻý> Encouraging activity with antibiotic-free protocol but not with vancomycin preconditioning Nov 14, 2022
<ѻý>Oral, Hormone-Free Med Reduces Hot Flashes in Breast Cancer Patientsѻý> Q-122 was effective, well-tolerated in those on oral adjuvant endocrine therapy Nov 11, 2022
<ѻý>Terry Bradshaw's Merkel Cell Carcinomaѻý> After beating bladder cancer, the Hall of Fame quarterback was diagnosed with a rare skin tumor Nov 10, 2022
<ѻý>Role of Cytoreductive Nephrectomy Unclear for Dedifferentiated Kidney Cancerѻý> Thirteen-month survival gain falls short of statistical significance in observational study Nov 10, 2022
<ѻý>Immune Stimulator May Enhance Targeted Therapy's Activity in Metastatic RCCѻý> Numerical advantage in median survival, response rate, durability with dendritic-cell agent Nov 09, 2022
<ѻý>Immunotherapy Doublet Shows Promise for Nonsurgical Control of Small Kidney Cancersѻý> Nivolumab/ipilimumab achieves 1-year PFS of 100% in unresectable T1N0M0 tumors Nov 07, 2022
<ѻý>Lucky to Be Scopedѻý> My screening colonoscopy went really well, but how many people don't get the chance to have one? Nov 07, 2022
<ѻý>Probiotic May Rev Up Response to Immunotherapy in Advanced Kidney Cancerѻý> Dramatic slowing of disease progression, prolonged responses with microbiome modulator Nov 06, 2022
<ѻý>Psilocybin for Depression; What's the Best Direct Oral Anticoagulant?ѻý> Also in TTHealthWatch: hormone therapy to prevent chronic disease Nov 05, 2022 podcast
<ѻý>Boys Who Lose Excess Pounds by College May Still See Elevated Cancer Riskѻý> Long-term Swedish study suggests early obesity "programming" in males has lasting impact Nov 04, 2022
<ѻý>Treatment De-Escalation Shows Promise in Testicular Cancerѻý> Early trial misses primary PFS endpoint, but "favorable" outcomes seen nonetheless Nov 03, 2022
<ѻý>Lenalidomide-Induced Second Cancer Risk Limited to Multiple Myelomaѻý> No increased risk to patients with other hematologic malignancies, meta-analysis shows Nov 02, 2022
<ѻý>Study: U.S. Chemo Regimen for Ewing Sarcoma Should Be International Standardѻý> Europe and other countries have already followed suit Nov 01, 2022
<ѻý>My Risk Revealed: A Confirmed BRCA2 Mutationѻý> My dad's cancer diagnosis offered me invaluable information Oct 30, 2022
<ѻý>Could a Plant-Based Diet Benefit Men's Health Below the Belt?ѻý> Analysis suggests protective nature of veggie-heavy diet in prostate cancer and more Oct 30, 2022
<ѻý>Good, and Safe, Results Tied to Oral Testosterone in Men With Deficiencyѻý> Meta-analysis should spur more research on newer formulations, researcher says Oct 30, 2022
<ѻý>Metastasis-Directed Therapy for Prostate Cancer Increases PFS, Time off Hormonesѻý> Radiotherapy led to "dramatic" slowing of progression, increased time with normal testosterone Oct 27, 2022
<ѻý>Ablative MR-Guided RT Shows Promise in Pancreatic Cancerѻý> SMART safe in patients with borderline or locally advanced cancer, with encouraging early OS data Oct 27, 2022
<ѻý>Study Suggests Potential to Skip Surgery for Selected Breast Cancer Patientsѻý> No recurrences in 2 years after pathologic complete response in TNBC, HER2-positive tumors Oct 26, 2022
<ѻý>Concurrent Boost During Hypofractionated RT Proves Its Worth in Early Breast Cancerѻý> Reduces treatment time, noninferior to conventional RT with sequential boost after lumpectomy Oct 26, 2022
<ѻý>Radiation for Asymptomatic Bone Metastases May Improve Cancer Survivalѻý> Fewer skeletal events, less pain unexpectedly followed by longer life Oct 26, 2022